Sen. Don Harmon

Filed: 3/1/2012

 

 


 

 


 
09700SB3329sam001LRB097 18939 CEL 66275 a

1
AMENDMENT TO SENATE BILL 3329

2    AMENDMENT NO. ______. Amend Senate Bill 3329 by replacing
3everything after the enacting clause with the following:
 
4    "Section 5. The Clinical Psychologist Licensing Act is
5amended by changing Sections 2 and 15 and by adding Sections
64.1, 4.2, 4.3, 4.4, 4.5, and 4.6 as follows:
 
7    (225 ILCS 15/2)  (from Ch. 111, par. 5352)
8    (Section scheduled to be repealed on January 1, 2017)
9    Sec. 2. Definitions. As used in this Act:
10        (1) "Department" means the Department of Financial and
11    Professional Regulation.
12        (2) "Secretary" means the Secretary of Financial and
13    Professional Regulation.
14        (3) "Board" means the Clinical Psychologists Licensing
15    and Disciplinary Board appointed by the Secretary.
16        (4) "Person" means an individual, association,

 

 

09700SB3329sam001- 2 -LRB097 18939 CEL 66275 a

1    partnership or corporation.
2        (5) "Clinical psychology" means the independent
3    evaluation, classification and treatment of mental,
4    emotional, behavioral or nervous disorders or conditions,
5    developmental disabilities, alcoholism and substance
6    abuse, disorders of habit or conduct, the psychological
7    aspects of physical illness. The practice of clinical
8    psychology includes psychoeducational evaluation, therapy,
9    remediation and consultation, the use of psychological and
10    neuropsychological testing, assessment, psychotherapy,
11    psychoanalysis, hypnosis, biofeedback, and behavioral
12    modification when any of these are used for the purpose of
13    preventing or eliminating psychopathology, or for the
14    amelioration of psychological disorders of individuals or
15    groups. "Clinical psychology" does not include the use of
16    hypnosis by unlicensed persons pursuant to Section 3.
17        (6) A person represents himself to be a "clinical
18    psychologist" within the meaning of this Act when he or she
19    holds himself out to the public by any title or description
20    of services incorporating the words "psychological",
21    "psychologic", "psychologist", "psychology", or "clinical
22    psychologist" or under such title or description offers to
23    render or renders clinical psychological services as
24    defined in paragraph (7) of this Section to individuals,
25    corporations, or the public for remuneration.
26        (7) "Clinical psychological services" refers to any

 

 

09700SB3329sam001- 3 -LRB097 18939 CEL 66275 a

1    services under paragraph (5) of this Section if the words
2    "psychological", "psychologic", "psychologist",
3    "psychology" or "clinical psychologist" are used to
4    describe such services by the person or organization
5    offering to render or rendering them.
6        (8) "Drugs" has the meaning given to that term in the
7    Pharmacy Practice Act.
8        (9) "Medicines" has the meaning given to that term in
9    the Pharmacy Practice Act.
10        (10) "Prescription" means an order for a drug,
11    laboratory test, or any medicines, devices, or treatments,
12    including controlled substances, as defined by State law.
13        (11) "Prescriptive authority" means the authority to
14    prescribe and dispense drugs, medicines, or other
15    treatment procedures.
16        (12) "Prescribing psychologist" means a licensed,
17    doctoral level psychologist who has undergone specialized
18    training, has passed an examination accepted by the Board,
19    and has received a current certificate granting
20    prescriptive authority that has not been revoked or
21    suspended from the Board.
22    This Act shall not apply to persons lawfully carrying on
23their particular profession or business under any valid
24existing regulatory Act of the State.
25(Source: P.A. 94-870, eff. 6-16-06.)
 

 

 

09700SB3329sam001- 4 -LRB097 18939 CEL 66275 a

1    (225 ILCS 15/4.1 new)
2    (Section scheduled to be repealed on January 1, 2017)
3    Sec. 4.1. Prescribing psychologist certification;
4prescriptive authority. The Board shall grant certification as
5prescribing psychologists to doctoral level psychologists
6licensed under this Act. This certification shall grant
7prescribing psychologists prescriptive authority to prescribe
8and dispense those drugs used in the treatment of mental,
9emotional, and psychological disorders in accordance with
10applicable State and federal laws. The Board shall develop and
11implement procedures and criteria for reviewing educational
12and training credentials for the certification process and the
13extent of prescriptive authority, in accordance with current
14standards of professional practice. The Board may seek the
15advice of other State agencies with relevant experience in
16devising certification procedures and criteria.
 
17    (225 ILCS 15/4.2 new)
18    (Section scheduled to be repealed on January 1, 2017)
19    Sec. 4.2. Prescribing psychologist certification
20application requirements.
21    (a) The Department shall grant prescribing psychologist
22certification to a psychologist who applies for certification
23and demonstrates, by official transcript or other official
24evidence satisfactory to the Board:
25        (1) the completion of a doctoral program in psychology

 

 

09700SB3329sam001- 5 -LRB097 18939 CEL 66275 a

1    from a regionally accredited university or professional
2    school or, if the program is not accredited at the time of
3    graduation, completion of a doctoral program in psychology
4    that meets recognized acceptable professional standards,
5    as determined by the Board;
6        (2) possession of a current and valid license to
7    practice psychology in this State;
8        (3) the completion of an organized program of intensive
9    didactic instruction, as defined by the Board, within the
10    5-year period immediately before the date of application,
11    consisting of a minimum of 450 contact hours and the
12    following core areas of instruction:
13            (A) neuroscience;
14            (B) pharmacology;
15            (C) psychopharmacology;
16            (D) physiology;
17            (E) pathophysiology;
18            (F) appropriate and relevant physical and
19        laboratory assessment; and
20            (G) clinical pharmacotherapeutics;
21        (4) the procurement of supervised and relevant
22    clinical experience sufficient to achieve competency in
23    the treatment of a diverse patient population under the
24    direction of qualified practitioners, as determined by the
25    Board, within the 5-year period immediately preceding the
26    date of application that includes the pharmacological

 

 

09700SB3329sam001- 6 -LRB097 18939 CEL 66275 a

1    treatment of a minimum of 100 patients under the full
2    supervision and control of a designated qualified
3    practitioner who shall then certify the clinical
4    competency of the candidate for certification; and the
5    completion of a minimum of 80 hours of supervised training
6    in physical assessment under the full supervision and
7    control of a designated qualified practitioner; and
8        (5) the successful completion of a certifying
9    examination stipulated by the Board.
10    (b) The Department shall grant certification to a
11psychologist who applies for certification as a prescribing
12psychologist and has completed the requirements specified in
13subsection (a). If an applicant has met the academic
14requirements in paragraph (3) of subsection (a) more than 5
15years prior to the application for prescriptive authority, then
16the applicant shall complete 24 hours of continuing education
17in the 2 years immediately prior to application, as specified
18in Section 4.3 of this Act to be eligible for certification as
19a prescribing psychologist.
 
20    (225 ILCS 15/4.3 new)
21    (Section scheduled to be repealed on January 1, 2017)
22    Sec. 4.3. Renewal of prescribing psychologist
23certification.
24    (a) The Board shall establish, by rule, a method for the
25annual renewal of prescribing psychologist certification at

 

 

09700SB3329sam001- 7 -LRB097 18939 CEL 66275 a

1the time of or in conjunction with the renewal of clinical
2psychology licenses.
3    (b) Each applicant for renewal of prescribing psychologist
4certification shall present satisfactory evidence to the Board
5demonstrating the completion of 24 required hours of
6instruction relevant to prescriptive authority during the 24
7months prior to application for renewal.
 
8    (225 ILCS 15/4.4 new)
9    (Section scheduled to be repealed on January 1, 2017)
10    Sec. 4.4. Prescribing practices.
11    (a) Every prescription by a prescribing psychologist shall
12(i) comply with all applicable State and federal laws, (ii) be
13identified as issued by the psychologist as a prescribing
14psychologist, and (iii) include the prescribing psychologist's
15identification number, as assigned by the Board.
16    (b) Records of all prescriptions shall be maintained in
17patient records.
18    (c) A prescribing psychologist shall not delegate the
19prescriptive authority to any other person.
20    (d) A prescribing psychologist shall maintain an ongoing
21collaborative relationship with the health care practitioner
22who oversees the patient's general medical care to ensure that
23(i) all necessary medical examinations are conducted, (ii) all
24medical and psychological issues are discussed, (iii) no
25prescribed medications are contraindicated, and (iv) all

 

 

09700SB3329sam001- 8 -LRB097 18939 CEL 66275 a

1significant changes in the patient's medical or psychological
2condition are communicated.
3    (e) For the purposes of this Section:
4    "Collaborative relationship" means a cooperative working
5relationship between a prescribing psychologist and a health
6care practitioner in the provision of patient care, including
7diagnosis and cooperation in the management and delivery of
8physical and mental health care.
9    "Health care practitioner" means a health care
10professional who prescribes independently.
 
11    (225 ILCS 15/4.5 new)
12    (Section scheduled to be repealed on January 1, 2017)
13    Sec. 4.5. Controlled substance prescriptive authority.
14    (a) When authorized to prescribe controlled substances, a
15prescribing psychologist shall file, in a timely manner, any
16individual Drug Enforcement Agency (DEA) registrations and
17identification numbers with the Board.
18    (b) The Board shall maintain current records of every
19prescribing psychologist, including DEA registration and
20identification numbers.
 
21    (225 ILCS 15/4.6 new)
22    (Section scheduled to be repealed on January 1, 2017)
23    Sec. 4.6. State Board of Pharmacy interaction.
24    (a) The Board shall transmit to the State Board of Pharmacy

 

 

09700SB3329sam001- 9 -LRB097 18939 CEL 66275 a

1an annual list of prescribing psychologists containing the
2following information:
3        (1) the name of the psychologist;
4        (2) the prescribing psychologist's identification
5    number assigned by the Board; and
6        (3) the effective dates of the prescribing
7    psychologist's certification.
8    (b) The Board shall promptly forward to the Board of
9Pharmacy the names and titles of psychologists added to or
10deleted from the annual list of prescribing psychologists.
11    (c) The Board shall notify the State Board of Pharmacy, in
12a timely manner, upon termination, suspension, or
13reinstatement of a psychologist's certification as a
14prescribing psychologist.
 
15    (225 ILCS 15/15)  (from Ch. 111, par. 5365)
16    (Section scheduled to be repealed on January 1, 2017)
17    Sec. 15. Disciplinary action; grounds. The Department may
18refuse to issue, refuse to renew, suspend, or revoke any
19license, or may place on probation, censure, reprimand, or take
20other disciplinary action deemed appropriate by the
21Department, including the imposition of fines not to exceed
22$10,000 for each violation, with regard to any license issued
23under the provisions of this Act for any one or a combination
24of the following reasons:
25        (1) Conviction of, or entry of a plea of guilty or nolo

 

 

09700SB3329sam001- 10 -LRB097 18939 CEL 66275 a

1    contendere to, any crime that is a felony under the laws of
2    the United States or any state or territory thereof or that
3    is a misdemeanor of which an essential element is
4    dishonesty, or any crime that is directly related to the
5    practice of the profession.
6        (2) Gross negligence in the rendering of clinical
7    psychological services.
8        (3) Using fraud or making any misrepresentation in
9    applying for a license or in passing the examination
10    provided for in this Act.
11        (4) Aiding or abetting or conspiring to aid or abet a
12    person, not a clinical psychologist licensed under this
13    Act, in representing himself or herself as so licensed or
14    in applying for a license under this Act.
15        (5) Violation of any provision of this Act or the rules
16    promulgated thereunder.
17        (6) Professional connection or association with any
18    person, firm, association, partnership or corporation
19    holding himself, herself, themselves, or itself out in any
20    manner contrary to this Act.
21        (7) Unethical, unauthorized or unprofessional conduct
22    as defined by rule. In establishing those rules, the
23    Department shall consider, though is not bound by, the
24    ethical standards for psychologists promulgated by
25    recognized national psychology associations.
26        (8) Aiding or assisting another person in violating any

 

 

09700SB3329sam001- 11 -LRB097 18939 CEL 66275 a

1    provisions of this Act or the rules promulgated thereunder.
2        (9) Failing to provide, within 60 days, information in
3    response to a written request made by the Department.
4        (10) Habitual or excessive use or addiction to alcohol,
5    narcotics, stimulants, or any other chemical agent or drug
6    that results in a clinical psychologist's inability to
7    practice with reasonable judgment, skill or safety.
8        (11) Discipline by another state, territory, the
9    District of Columbia or foreign country, if at least one of
10    the grounds for the discipline is the same or substantially
11    equivalent to those set forth herein.
12        (12) Directly or indirectly giving or receiving from
13    any person, firm, corporation, association or partnership
14    any fee, commission, rebate, or other form of compensation
15    for any professional service not actually or personally
16    rendered. Nothing in this paragraph (12) affects any bona
17    fide independent contractor or employment arrangements
18    among health care professionals, health facilities, health
19    care providers, or other entities, except as otherwise
20    prohibited by law. Any employment arrangements may include
21    provisions for compensation, health insurance, pension, or
22    other employment benefits for the provision of services
23    within the scope of the licensee's practice under this Act.
24    Nothing in this paragraph (12) shall be construed to
25    require an employment arrangement to receive professional
26    fees for services rendered.

 

 

09700SB3329sam001- 12 -LRB097 18939 CEL 66275 a

1        (13) A finding by the Board that the licensee, after
2    having his or her license placed on probationary status has
3    violated the terms of probation.
4        (14) Willfully making or filing false records or
5    reports, including but not limited to, false records or
6    reports filed with State agencies or departments.
7        (15) Physical illness, including but not limited to,
8    deterioration through the aging process, mental illness or
9    disability that results in the inability to practice the
10    profession with reasonable judgment, skill and safety.
11        (16) Willfully failing to report an instance of
12    suspected child abuse or neglect as required by the Abused
13    and Neglected Child Reporting Act.
14        (17) Being named as a perpetrator in an indicated
15    report by the Department of Children and Family Services
16    pursuant to the Abused and Neglected Child Reporting Act,
17    and upon proof by clear and convincing evidence that the
18    licensee has caused a child to be an abused child or
19    neglected child as defined in the Abused and Neglected
20    Child Reporting Act.
21        (18) Violation of the Health Care Worker Self-Referral
22    Act.
23        (19) Making a material misstatement in furnishing
24    information to the Department, any other State or federal
25    agency, or any other entity.
26        (20) Failing to report to the Department any adverse

 

 

09700SB3329sam001- 13 -LRB097 18939 CEL 66275 a

1    judgment, settlement, or award arising from a liability
2    claim related to an act or conduct similar to an act or
3    conduct that would constitute grounds for action as set
4    forth in this Section.
5        (21) Failing to report to the Department any adverse
6    final action taken against a licensee or applicant by
7    another licensing jurisdiction, including any other state
8    or territory of the United States or any foreign state or
9    country, or any peer review body, health care institution,
10    professional society or association related to the
11    profession, governmental agency, law enforcement agency,
12    or court for an act or conduct similar to an act or conduct
13    that would constitute grounds for disciplinary action as
14    set forth in this Section.
15    The entry of an order by any circuit court establishing
16that any person holding a license under this Act is subject to
17involuntary admission or judicial admission as provided for in
18the Mental Health and Developmental Disabilities Code,
19operates as an automatic suspension of that license. That
20person may have his or her license restored only upon the
21determination by a circuit court that the patient is no longer
22subject to involuntary admission or judicial admission and the
23issuance of an order so finding and discharging the patient and
24upon the Board's recommendation to the Department that the
25license be restored. Where the circumstances so indicate, the
26Board may recommend to the Department that it require an

 

 

09700SB3329sam001- 14 -LRB097 18939 CEL 66275 a

1examination prior to restoring any license so automatically
2suspended.
3    The Department may refuse to issue or may suspend the
4license of any person who fails to file a return, or to pay the
5tax, penalty or interest shown in a filed return, or to pay any
6final assessment of the tax penalty or interest, as required by
7any tax Act administered by the Illinois Department of Revenue,
8until such time as the requirements of any such tax Act are
9satisfied.
10    In enforcing this Section, the Board upon a showing of a
11possible violation may compel any person licensed to practice
12under this Act, or who has applied for licensure or
13certification pursuant to this Act, to submit to a mental or
14physical examination, or both, as required by and at the
15expense of the Department. The examining physicians or clinical
16psychologists shall be those specifically designated by the
17Board. The Board or the Department may order the examining
18physician or clinical psychologist to present testimony
19concerning this mental or physical examination of the licensee
20or applicant. No information shall be excluded by reason of any
21common law or statutory privilege relating to communications
22between the licensee or applicant and the examining physician
23or clinical psychologist. The person to be examined may have,
24at his or her own expense, another physician or clinical
25psychologist of his or her choice present during all aspects of
26the examination. Failure of any person to submit to a mental or

 

 

09700SB3329sam001- 15 -LRB097 18939 CEL 66275 a

1physical examination, when directed, shall be grounds for
2suspension of a license until the person submits to the
3examination if the Board finds, after notice and hearing, that
4the refusal to submit to the examination was without reasonable
5cause.
6    If the Board finds a person unable to practice because of
7the reasons set forth in this Section, the Board may require
8that person to submit to care, counseling or treatment by
9physicians or clinical psychologists approved or designated by
10the Board, as a condition, term, or restriction for continued,
11reinstated, or renewed licensure to practice; or, in lieu of
12care, counseling or treatment, the Board may recommend to the
13Department to file a complaint to immediately suspend, revoke
14or otherwise discipline the license of the person. Any person
15whose license was granted, continued, reinstated, renewed,
16disciplined or supervised subject to such terms, conditions or
17restrictions, and who fails to comply with such terms,
18conditions or restrictions, shall be referred to the Secretary
19for a determination as to whether the person shall have his or
20her license suspended immediately, pending a hearing by the
21Board.
22    In instances in which the Secretary immediately suspends a
23person's license under this Section, a hearing on that person's
24license must be convened by the Board within 15 days after the
25suspension and completed without appreciable delay. The Board
26shall have the authority to review the subject person's record

 

 

09700SB3329sam001- 16 -LRB097 18939 CEL 66275 a

1of treatment and counseling regarding the impairment, to the
2extent permitted by applicable federal statutes and
3regulations safeguarding the confidentiality of medical
4records.
5    A person licensed under this Act and affected under this
6Section shall be afforded an opportunity to demonstrate to the
7Board that he or she can resume practice in compliance with
8acceptable and prevailing standards under the provisions of his
9or her license.
10    The Board shall prescribe, by rule, criteria for
11disciplining, suspending, or revoking the prescriptive
12authority of a prescribing psychologist. The Board shall have
13the power and duty to require remediation, suspension, or
14revocation of a prescribing psychologist's certification for a
15specified period of time determined by the Board.
16(Source: P.A. 96-1482, eff. 11-29-10.)
 
17    Section 10. The Nurse Practice Act is amended by changing
18Section 50-10 as follows:
 
19    (225 ILCS 65/50-10)   (was 225 ILCS 65/5-10)
20    (Section scheduled to be repealed on January 1, 2018)
21    Sec. 50-10. Definitions. Each of the following terms, when
22used in this Act, shall have the meaning ascribed to it in this
23Section, except where the context clearly indicates otherwise:
24    "Academic year" means the customary annual schedule of

 

 

09700SB3329sam001- 17 -LRB097 18939 CEL 66275 a

1courses at a college, university, or approved school,
2customarily regarded as the school year as distinguished from
3the calendar year.
4    "Advanced practice nurse" or "APN" means a person who has
5met the qualifications for a (i) certified nurse midwife (CNM);
6(ii) certified nurse practitioner (CNP); (iii) certified
7registered nurse anesthetist (CRNA); or (iv) clinical nurse
8specialist (CNS) and has been licensed by the Department. All
9advanced practice nurses licensed and practicing in the State
10of Illinois shall use the title APN and may use specialty
11speciality credentials after their name.
12    "Approved program of professional nursing education" and
13"approved program of practical nursing education" are programs
14of professional or practical nursing, respectively, approved
15by the Department under the provisions of this Act.
16    "Board" means the Board of Nursing appointed by the
17Secretary.
18    "Collaboration" means a process involving 2 or more health
19care professionals working together, each contributing one's
20respective area of expertise to provide more comprehensive
21patient care.
22    "Consultation" means the process whereby an advanced
23practice nurse seeks the advice or opinion of another health
24care professional.
25    "Credentialed" means the process of assessing and
26validating the qualifications of a health care professional.

 

 

09700SB3329sam001- 18 -LRB097 18939 CEL 66275 a

1    "Current nursing practice update course" means a planned
2nursing education curriculum approved by the Department
3consisting of activities that have educational objectives,
4instructional methods, content or subject matter, clinical
5practice, and evaluation methods, related to basic review and
6updating content and specifically planned for those nurses
7previously licensed in the United States or its territories and
8preparing for reentry into nursing practice.
9    "Dentist" means a person licensed to practice dentistry
10under the Illinois Dental Practice Act.
11    "Department" means the Department of Financial and
12Professional Regulation.
13    "Impaired nurse" means a nurse licensed under this Act who
14is unable to practice with reasonable skill and safety because
15of a physical or mental disability as evidenced by a written
16determination or written consent based on clinical evidence,
17including loss of motor skills, abuse of drugs or alcohol, or a
18psychiatric disorder, of sufficient degree to diminish his or
19her ability to deliver competent patient care.
20    "License-pending advanced practice nurse" means a
21registered professional nurse who has completed all
22requirements for licensure as an advanced practice nurse except
23the certification examination and has applied to take the next
24available certification exam and received a temporary license
25from the Department.
26    "License-pending registered nurse" means a person who has

 

 

09700SB3329sam001- 19 -LRB097 18939 CEL 66275 a

1passed the Department-approved registered nurse licensure exam
2and has applied for a license from the Department. A
3license-pending registered nurse shall use the title "RN lic
4pend" on all documentation related to nursing practice.
5    "Physician" means a person licensed to practice medicine in
6all its branches under the Medical Practice Act of 1987.
7    "Podiatrist" means a person licensed to practice podiatry
8under the Podiatric Medical Practice Act of 1987.
9    "Practical nurse" or "licensed practical nurse" means a
10person who is licensed as a practical nurse under this Act and
11practices practical nursing as defined in this Act. Only a
12practical nurse licensed under this Act is entitled to use the
13title "licensed practical nurse" and the abbreviation
14"L.P.N.".
15    "Practical nursing" means the performance of nursing acts
16requiring the basic nursing knowledge, judgement, and skill
17acquired by means of completion of an approved practical
18nursing education program. Practical nursing includes
19assisting in the nursing process as delegated by a registered
20professional nurse or an advanced practice nurse. The practical
21nurse may work under the direction of a licensed physician,
22dentist, podiatrist, or other health care professional
23determined by the Department.
24    "Privileged" means the authorization granted by the
25governing body of a healthcare facility, agency, or
26organization to provide specific patient care services within

 

 

09700SB3329sam001- 20 -LRB097 18939 CEL 66275 a

1well-defined limits, based on qualifications reviewed in the
2credentialing process.
3    "Registered Nurse" or "Registered Professional Nurse"
4means a person who is licensed as a professional nurse under
5this Act and practices nursing as defined in this Act. Only a
6registered nurse licensed under this Act is entitled to use the
7titles "registered nurse" and "registered professional nurse"
8and the abbreviation, "R.N.".
9    "Registered professional nursing practice" is a scientific
10process founded on a professional body of knowledge; it is a
11learned profession based on the understanding of the human
12condition across the life span and environment and includes all
13nursing specialties specialities and means the performance of
14any nursing act based upon professional knowledge, judgment,
15and skills acquired by means of completion of an approved
16professional nursing education program. A registered
17professional nurse provides holistic nursing care through the
18nursing process to individuals, groups, families, or
19communities, that includes but is not limited to: (1) the
20assessment of healthcare needs, nursing diagnosis, planning,
21implementation, and nursing evaluation; (2) the promotion,
22maintenance, and restoration of health; (3) counseling,
23patient education, health education, and patient advocacy; (4)
24the administration of medications and treatments as prescribed
25by a physician licensed to practice medicine in all of its
26branches, a licensed dentist, a licensed podiatrist, a

 

 

09700SB3329sam001- 21 -LRB097 18939 CEL 66275 a

1prescribing psychologist, or a licensed optometrist or as
2prescribed by a physician assistant in accordance with written
3guidelines required under the Physician Assistant Practice Act
4of 1987 or by an advanced practice nurse in accordance with
5Article 65 of this Act; (5) the coordination and management of
6the nursing plan of care; (6) the delegation to and supervision
7of individuals who assist the registered professional nurse
8implementing the plan of care; and (7) teaching nursing
9students. The foregoing shall not be deemed to include those
10acts of medical diagnosis or prescription of therapeutic or
11corrective measures.
12    "Professional assistance program for nurses" means a
13professional assistance program that meets criteria
14established by the Board of Nursing and approved by the
15Secretary, which provides a non-disciplinary treatment
16approach for nurses licensed under this Act whose ability to
17practice is compromised by alcohol or chemical substance
18addiction.
19    "Secretary" means the Secretary of Financial and
20Professional Regulation.
21    "Unencumbered license" means a license issued in good
22standing.
23    "Written collaborative agreement" means a written
24agreement between an advanced practice nurse and a
25collaborating physician, dentist, or podiatrist pursuant to
26Section 65-35.

 

 

09700SB3329sam001- 22 -LRB097 18939 CEL 66275 a

1(Source: P.A. 95-639, eff. 10-5-07; revised 11-18-11.)
 
2    Section 15. The Pharmacy Practice Act is amended by
3changing Sections 3 and 4 as follows:
 
4    (225 ILCS 85/3)
5    (Section scheduled to be repealed on January 1, 2018)
6    Sec. 3. Definitions. For the purpose of this Act, except
7where otherwise limited therein:
8    (a) "Pharmacy" or "drugstore" means and includes every
9store, shop, pharmacy department, or other place where
10pharmacist care is provided by a pharmacist (1) where drugs,
11medicines, or poisons are dispensed, sold or offered for sale
12at retail, or displayed for sale at retail; or (2) where
13prescriptions of physicians, dentists, advanced practice
14nurses, physician assistants, veterinarians, podiatrists,
15prescribing psychologists, or optometrists, within the limits
16of their licenses, are compounded, filled, or dispensed; or (3)
17which has upon it or displayed within it, or affixed to or used
18in connection with it, a sign bearing the word or words
19"Pharmacist", "Druggist", "Pharmacy", "Pharmaceutical Care",
20"Apothecary", "Drugstore", "Medicine Store", "Prescriptions",
21"Drugs", "Dispensary", "Medicines", or any word or words of
22similar or like import, either in the English language or any
23other language; or (4) where the characteristic prescription
24sign (Rx) or similar design is exhibited; or (5) any store, or

 

 

09700SB3329sam001- 23 -LRB097 18939 CEL 66275 a

1shop, or other place with respect to which any of the above
2words, objects, signs or designs are used in any advertisement.
3    (b) "Drugs" means and includes (l) articles recognized in
4the official United States Pharmacopoeia/National Formulary
5(USP/NF), or any supplement thereto and being intended for and
6having for their main use the diagnosis, cure, mitigation,
7treatment or prevention of disease in man or other animals, as
8approved by the United States Food and Drug Administration, but
9does not include devices or their components, parts, or
10accessories; and (2) all other articles intended for and having
11for their main use the diagnosis, cure, mitigation, treatment
12or prevention of disease in man or other animals, as approved
13by the United States Food and Drug Administration, but does not
14include devices or their components, parts, or accessories; and
15(3) articles (other than food) having for their main use and
16intended to affect the structure or any function of the body of
17man or other animals; and (4) articles having for their main
18use and intended for use as a component or any articles
19specified in clause (l), (2) or (3); but does not include
20devices or their components, parts or accessories.
21    (c) "Medicines" means and includes all drugs intended for
22human or veterinary use approved by the United States Food and
23Drug Administration.
24    (d) "Practice of pharmacy" means (1) the interpretation and
25the provision of assistance in the monitoring, evaluation, and
26implementation of prescription drug orders; (2) the dispensing

 

 

09700SB3329sam001- 24 -LRB097 18939 CEL 66275 a

1of prescription drug orders; (3) participation in drug and
2device selection; (4) drug administration limited to the
3administration of oral, topical, injectable, and inhalation as
4follows: in the context of patient education on the proper use
5or delivery of medications; vaccination of patients 14 years of
6age and older pursuant to a valid prescription or standing
7order, by a physician licensed to practice medicine in all its
8branches, upon completion of appropriate training, including
9how to address contraindications and adverse reactions set
10forth by rule, with notification to the patient's physician and
11appropriate record retention, or pursuant to hospital pharmacy
12and therapeutics committee policies and procedures; (5) drug
13regimen review; (6) drug or drug-related research; (7) the
14provision of patient counseling; (8) the practice of
15telepharmacy; (9) the provision of those acts or services
16necessary to provide pharmacist care; (10) medication therapy
17management; and (11) the responsibility for compounding and
18labeling of drugs and devices (except labeling by a
19manufacturer, repackager, or distributor of non-prescription
20drugs and commercially packaged legend drugs and devices),
21proper and safe storage of drugs and devices, and maintenance
22of required records. A pharmacist who performs any of the acts
23defined as the practice of pharmacy in this State must be
24actively licensed as a pharmacist under this Act.
25    (e) "Prescription" means and includes any written, oral,
26facsimile, or electronically transmitted order for drugs or

 

 

09700SB3329sam001- 25 -LRB097 18939 CEL 66275 a

1medical devices, issued by a physician licensed to practice
2medicine in all its branches, dentist, veterinarian, or
3podiatrist, or optometrist, within the limits of their
4licenses, by a physician assistant in accordance with
5subsection (f) of Section 4, or by an advanced practice nurse
6in accordance with subsection (g) of Section 4, containing the
7following: (l) name of the patient; (2) date when prescription
8was issued; (3) name and strength of drug or description of the
9medical device prescribed; and (4) quantity; (5) directions for
10use; (6) prescriber's name, address, and signature; and (7) DEA
11number where required, for controlled substances. The
12prescription may, but is not required to, list the illness,
13disease, or condition for which the drug or device is being
14prescribed. DEA numbers shall not be required on inpatient drug
15orders.
16    (f) "Person" means and includes a natural person,
17copartnership, association, corporation, government entity, or
18any other legal entity.
19    (g) "Department" means the Department of Financial and
20Professional Regulation.
21    (h) "Board of Pharmacy" or "Board" means the State Board of
22Pharmacy of the Department of Financial and Professional
23Regulation.
24    (i) "Secretary" means the Secretary of Financial and
25Professional Regulation.
26    (j) "Drug product selection" means the interchange for a

 

 

09700SB3329sam001- 26 -LRB097 18939 CEL 66275 a

1prescribed pharmaceutical product in accordance with Section
225 of this Act and Section 3.14 of the Illinois Food, Drug and
3Cosmetic Act.
4    (k) "Inpatient drug order" means an order issued by an
5authorized prescriber for a resident or patient of a facility
6licensed under the Nursing Home Care Act, the ID/DD Community
7Care Act, the Specialized Mental Health Rehabilitation Act, or
8the Hospital Licensing Act, or "An Act in relation to the
9founding and operation of the University of Illinois Hospital
10and the conduct of University of Illinois health care
11programs", approved July 3, 1931, as amended, or a facility
12which is operated by the Department of Human Services (as
13successor to the Department of Mental Health and Developmental
14Disabilities) or the Department of Corrections.
15    (k-5) "Pharmacist" means an individual health care
16professional and provider currently licensed by this State to
17engage in the practice of pharmacy.
18    (l) "Pharmacist in charge" means the licensed pharmacist
19whose name appears on a pharmacy license and who is responsible
20for all aspects of the operation related to the practice of
21pharmacy.
22    (m) "Dispense" or "dispensing" means the interpretation,
23evaluation, and implementation of a prescription drug order,
24including the preparation and delivery of a drug or device to a
25patient or patient's agent in a suitable container
26appropriately labeled for subsequent administration to or use

 

 

09700SB3329sam001- 27 -LRB097 18939 CEL 66275 a

1by a patient in accordance with applicable State and federal
2laws and regulations. "Dispense" or "dispensing" does not mean
3the physical delivery to a patient or a patient's
4representative in a home or institution by a designee of a
5pharmacist or by common carrier. "Dispense" or "dispensing"
6also does not mean the physical delivery of a drug or medical
7device to a patient or patient's representative by a
8pharmacist's designee within a pharmacy or drugstore while the
9pharmacist is on duty and the pharmacy is open.
10    (n) "Nonresident pharmacy" means a pharmacy that is located
11in a state, commonwealth, or territory of the United States,
12other than Illinois, that delivers, dispenses, or distributes,
13through the United States Postal Service, commercially
14acceptable parcel delivery service, or other common carrier, to
15Illinois residents, any substance which requires a
16prescription.
17    (o) "Compounding" means the preparation and mixing of
18components, excluding flavorings, (1) as the result of a
19prescriber's prescription drug order or initiative based on the
20prescriber-patient-pharmacist relationship in the course of
21professional practice or (2) for the purpose of, or incident
22to, research, teaching, or chemical analysis and not for sale
23or dispensing. "Compounding" includes the preparation of drugs
24or devices in anticipation of receiving prescription drug
25orders based on routine, regularly observed dispensing
26patterns. Commercially available products may be compounded

 

 

09700SB3329sam001- 28 -LRB097 18939 CEL 66275 a

1for dispensing to individual patients only if all of the
2following conditions are met: (i) the commercial product is not
3reasonably available from normal distribution channels in a
4timely manner to meet the patient's needs and (ii) the
5prescribing practitioner has requested that the drug be
6compounded.
7    (p) (Blank).
8    (q) (Blank).
9    (r) "Patient counseling" means the communication between a
10pharmacist or a student pharmacist under the supervision of a
11pharmacist and a patient or the patient's representative about
12the patient's medication or device for the purpose of
13optimizing proper use of prescription medications or devices.
14"Patient counseling" may include without limitation (1)
15obtaining a medication history; (2) acquiring a patient's
16allergies and health conditions; (3) facilitation of the
17patient's understanding of the intended use of the medication;
18(4) proper directions for use; (5) significant potential
19adverse events; (6) potential food-drug interactions; and (7)
20the need to be compliant with the medication therapy. A
21pharmacy technician may only participate in the following
22aspects of patient counseling under the supervision of a
23pharmacist: (1) obtaining medication history; (2) providing
24the offer for counseling by a pharmacist or student pharmacist;
25and (3) acquiring a patient's allergies and health conditions.
26    (s) "Patient profiles" or "patient drug therapy record"

 

 

09700SB3329sam001- 29 -LRB097 18939 CEL 66275 a

1means the obtaining, recording, and maintenance of patient
2prescription information, including prescriptions for
3controlled substances, and personal information.
4    (t) (Blank).
5    (u) "Medical device" means an instrument, apparatus,
6implement, machine, contrivance, implant, in vitro reagent, or
7other similar or related article, including any component part
8or accessory, required under federal law to bear the label
9"Caution: Federal law requires dispensing by or on the order of
10a physician". A seller of goods and services who, only for the
11purpose of retail sales, compounds, sells, rents, or leases
12medical devices shall not, by reasons thereof, be required to
13be a licensed pharmacy.
14    (v) "Unique identifier" means an electronic signature,
15handwritten signature or initials, thumb print, or other
16acceptable biometric or electronic identification process as
17approved by the Department.
18    (w) "Current usual and customary retail price" means the
19price that a pharmacy charges to a non-third-party payor.
20    (x) "Automated pharmacy system" means a mechanical system
21located within the confines of the pharmacy or remote location
22that performs operations or activities, other than compounding
23or administration, relative to storage, packaging, dispensing,
24or distribution of medication, and which collects, controls,
25and maintains all transaction information.
26    (y) "Drug regimen review" means and includes the evaluation

 

 

09700SB3329sam001- 30 -LRB097 18939 CEL 66275 a

1of prescription drug orders and patient records for (1) known
2allergies; (2) drug or potential therapy contraindications;
3(3) reasonable dose, duration of use, and route of
4administration, taking into consideration factors such as age,
5gender, and contraindications; (4) reasonable directions for
6use; (5) potential or actual adverse drug reactions; (6)
7drug-drug interactions; (7) drug-food interactions; (8)
8drug-disease contraindications; (9) therapeutic duplication;
9(10) patient laboratory values when authorized and available;
10(11) proper utilization (including over or under utilization)
11and optimum therapeutic outcomes; and (12) abuse and misuse.
12    (z) "Electronic transmission prescription" means any
13prescription order for which a facsimile or electronic image of
14the order is electronically transmitted from a licensed
15prescriber to a pharmacy. "Electronic transmission
16prescription" includes both data and image prescriptions.
17    (aa) "Medication therapy management services" means a
18distinct service or group of services offered by licensed
19pharmacists, physicians licensed to practice medicine in all
20its branches, advanced practice nurses authorized in a written
21agreement with a physician licensed to practice medicine in all
22its branches, or physician assistants authorized in guidelines
23by a supervising physician that optimize therapeutic outcomes
24for individual patients through improved medication use. In a
25retail or other non-hospital pharmacy, medication therapy
26management services shall consist of the evaluation of

 

 

09700SB3329sam001- 31 -LRB097 18939 CEL 66275 a

1prescription drug orders and patient medication records to
2resolve conflicts with the following:
3        (1) known allergies;
4        (2) drug or potential therapy contraindications;
5        (3) reasonable dose, duration of use, and route of
6    administration, taking into consideration factors such as
7    age, gender, and contraindications;
8        (4) reasonable directions for use;
9        (5) potential or actual adverse drug reactions;
10        (6) drug-drug interactions;
11        (7) drug-food interactions;
12        (8) drug-disease contraindications;
13        (9) identification of therapeutic duplication;
14        (10) patient laboratory values when authorized and
15    available;
16        (11) proper utilization (including over or under
17    utilization) and optimum therapeutic outcomes; and
18        (12) drug abuse and misuse.
19"Medication therapy management services" includes the
20following:
21        (1) documenting the services delivered and
22    communicating the information provided to patients'
23    prescribers within an appropriate time frame, not to exceed
24    48 hours;
25        (2) providing patient counseling designed to enhance a
26    patient's understanding and the appropriate use of his or

 

 

09700SB3329sam001- 32 -LRB097 18939 CEL 66275 a

1    her medications; and
2        (3) providing information, support services, and
3    resources designed to enhance a patient's adherence with
4    his or her prescribed therapeutic regimens.
5"Medication therapy management services" may also include
6patient care functions authorized by a physician licensed to
7practice medicine in all its branches for his or her identified
8patient or groups of patients under specified conditions or
9limitations in a standing order from the physician.
10"Medication therapy management services" in a licensed
11hospital may also include the following:
12        (1) reviewing assessments of the patient's health
13    status; and
14        (2) following protocols of a hospital pharmacy and
15    therapeutics committee with respect to the fulfillment of
16    medication orders.
17    (bb) "Pharmacist care" means the provision by a pharmacist
18of medication therapy management services, with or without the
19dispensing of drugs or devices, intended to achieve outcomes
20that improve patient health, quality of life, and comfort and
21enhance patient safety.
22    (cc) "Protected health information" means individually
23identifiable health information that, except as otherwise
24provided, is:
25        (1) transmitted by electronic media;
26        (2) maintained in any medium set forth in the

 

 

09700SB3329sam001- 33 -LRB097 18939 CEL 66275 a

1    definition of "electronic media" in the federal Health
2    Insurance Portability and Accountability Act; or
3        (3) transmitted or maintained in any other form or
4    medium.
5"Protected health information" does not include individually
6identifiable health information found in:
7        (1) education records covered by the federal Family
8    Educational Right and Privacy Act; or
9        (2) employment records held by a licensee in its role
10    as an employer.
11    (dd) "Standing order" means a specific order for a patient
12or group of patients issued by a physician licensed to practice
13medicine in all its branches in Illinois.
14    (ee) "Address of record" means the address recorded by the
15Department in the applicant's or licensee's application file or
16license file, as maintained by the Department's licensure
17maintenance unit.
18    (ff) "Home pharmacy" means the location of a pharmacy's
19primary operations.
20(Source: P.A. 96-339, eff. 7-1-10; 96-673, eff. 1-1-10;
2196-1000, eff. 7-2-10; 96-1353, eff. 7-28-10; 97-38, eff.
226-28-11; 97-227, eff. 1-1-12; revised 10-4-11.)
 
23    (225 ILCS 85/4)  (from Ch. 111, par. 4124)
24    (Section scheduled to be repealed on January 1, 2018)
25    Sec. 4. Exemptions. Nothing contained in any Section of

 

 

09700SB3329sam001- 34 -LRB097 18939 CEL 66275 a

1this Act shall apply to, or in any manner interfere with:
2    (a) the lawful practice of any physician licensed to
3practice medicine in all of its branches, dentist, podiatrist,
4veterinarian, prescribing psychologist, or therapeutically or
5diagnostically certified optometrist within the limits of his
6or her license, or prevent him or her from supplying to his or
7her bona fide patients such drugs, medicines, or poisons as may
8seem to him appropriate;
9    (b) the sale of compressed gases;
10    (c) the sale of patent or proprietary medicines and
11household remedies when sold in original and unbroken packages
12only, if such patent or proprietary medicines and household
13remedies be properly and adequately labeled as to content and
14usage and generally considered and accepted as harmless and
15nonpoisonous when used according to the directions on the
16label, and also do not contain opium or coca leaves, or any
17compound, salt or derivative thereof, or any drug which,
18according to the latest editions of the following authoritative
19pharmaceutical treatises and standards, namely, The United
20States Pharmacopoeia/National Formulary (USP/NF), the United
21States Dispensatory, and the Accepted Dental Remedies of the
22Council of Dental Therapeutics of the American Dental
23Association or any or either of them, in use on the effective
24date of this Act, or according to the existing provisions of
25the Federal Food, Drug, and Cosmetic Act and Regulations of the
26Department of Health and Human Services, Food and Drug

 

 

09700SB3329sam001- 35 -LRB097 18939 CEL 66275 a

1Administration, promulgated thereunder now in effect, is
2designated, described or considered as a narcotic, hypnotic,
3habit forming, dangerous, or poisonous drug;
4    (d) the sale of poultry and livestock remedies in original
5and unbroken packages only, labeled for poultry and livestock
6medication;
7    (e) the sale of poisonous substances or mixture of
8poisonous substances, in unbroken packages, for nonmedicinal
9use in the arts or industries or for insecticide purposes;
10provided, they are properly and adequately labeled as to
11content and such nonmedicinal usage, in conformity with the
12provisions of all applicable federal, state and local laws and
13regulations promulgated thereunder now in effect relating
14thereto and governing the same, and those which are required
15under such applicable laws and regulations to be labeled with
16the word "Poison", are also labeled with the word "Poison"
17printed thereon in prominent type and the name of a readily
18obtainable antidote with directions for its administration;
19    (f) the delegation of limited prescriptive authority by a
20physician licensed to practice medicine in all its branches to
21a physician assistant under Section 7.5 of the Physician
22Assistant Practice Act of 1987. This delegated authority under
23Section 7.5 of the Physician Assistant Practice Act of 1987
24may, but is not required to, include prescription of controlled
25substances, as defined in Article II of the Illinois Controlled
26Substances Act, in accordance with a written supervision

 

 

09700SB3329sam001- 36 -LRB097 18939 CEL 66275 a

1agreement; and
2    (g) the delegation of prescriptive authority by a physician
3licensed to practice medicine in all its branches or a licensed
4podiatrist to an advanced practice nurse in accordance with a
5written collaborative agreement under Sections 65-35 and 65-40
6of the Nurse Practice Act.
7(Source: P.A. 95-639, eff. 10-5-07; 96-189, eff. 8-10-09;
896-268, eff. 8-11-09.)
 
9    Section 20. The Illinois Controlled Substances Act is
10amended by changing Section 102 as follows:
 
11    (720 ILCS 570/102)  (from Ch. 56 1/2, par. 1102)
12    Sec. 102. Definitions. As used in this Act, unless the
13context otherwise requires:
14    (a) "Addict" means any person who habitually uses any drug,
15chemical, substance or dangerous drug other than alcohol so as
16to endanger the public morals, health, safety or welfare or who
17is so far addicted to the use of a dangerous drug or controlled
18substance other than alcohol as to have lost the power of self
19control with reference to his or her addiction.
20    (b) "Administer" means the direct application of a
21controlled substance, whether by injection, inhalation,
22ingestion, or any other means, to the body of a patient,
23research subject, or animal (as defined by the Humane
24Euthanasia in Animal Shelters Act) by:

 

 

09700SB3329sam001- 37 -LRB097 18939 CEL 66275 a

1        (1) a practitioner (or, in his or her presence, by his
2    or her authorized agent),
3        (2) the patient or research subject pursuant to an
4    order, or
5        (3) a euthanasia technician as defined by the Humane
6    Euthanasia in Animal Shelters Act.
7    (c) "Agent" means an authorized person who acts on behalf
8of or at the direction of a manufacturer, distributor,
9dispenser, prescriber, or practitioner. It does not include a
10common or contract carrier, public warehouseman or employee of
11the carrier or warehouseman.
12    (c-1) "Anabolic Steroids" means any drug or hormonal
13substance, chemically and pharmacologically related to
14testosterone (other than estrogens, progestins,
15corticosteroids, and dehydroepiandrosterone), and includes:
16    (i) 3[beta],17-dihydroxy-5a-androstane, 
17    (ii) 3[alpha],17[beta]-dihydroxy-5a-androstane, 
18    (iii) 5[alpha]-androstan-3,17-dione, 
19    (iv) 1-androstenediol (3[beta], 
20        17[beta]-dihydroxy-5[alpha]-androst-1-ene), 
21    (v) 1-androstenediol (3[alpha], 
22        17[beta]-dihydroxy-5[alpha]-androst-1-ene), 
23    (vi) 4-androstenediol  
24        (3[beta],17[beta]-dihydroxy-androst-4-ene), 
25    (vii) 5-androstenediol  
26        (3[beta],17[beta]-dihydroxy-androst-5-ene), 

 

 

09700SB3329sam001- 38 -LRB097 18939 CEL 66275 a

1    (viii) 1-androstenedione  
2        ([5alpha]-androst-1-en-3,17-dione), 
3    (ix) 4-androstenedione  
4        (androst-4-en-3,17-dione), 
5    (x) 5-androstenedione  
6        (androst-5-en-3,17-dione), 
7    (xi) bolasterone (7[alpha],17a-dimethyl-17[beta]- 
8        hydroxyandrost-4-en-3-one), 
9    (xii) boldenone (17[beta]-hydroxyandrost- 
10        1,4,-diene-3-one), 
11    (xiii) boldione (androsta-1,4- 
12        diene-3,17-dione), 
13    (xiv) calusterone (7[beta],17[alpha]-dimethyl-17 
14        [beta]-hydroxyandrost-4-en-3-one), 
15    (xv) clostebol (4-chloro-17[beta]- 
16        hydroxyandrost-4-en-3-one), 
17    (xvi) dehydrochloromethyltestosterone (4-chloro- 
18        17[beta]-hydroxy-17[alpha]-methyl- 
19        androst-1,4-dien-3-one), 
20    (xvii) desoxymethyltestosterone 
21    (17[alpha]-methyl-5[alpha] 
22        -androst-2-en-17[beta]-ol)(a.k.a., madol), 
23    (xviii) [delta]1-dihydrotestosterone (a.k.a.  
24        '1-testosterone') (17[beta]-hydroxy- 
25        5[alpha]-androst-1-en-3-one), 
26    (xix) 4-dihydrotestosterone (17[beta]-hydroxy- 

 

 

09700SB3329sam001- 39 -LRB097 18939 CEL 66275 a

1        androstan-3-one), 
2    (xx) drostanolone (17[beta]-hydroxy-2[alpha]-methyl- 
3        5[alpha]-androstan-3-one), 
4    (xxi) ethylestrenol (17[alpha]-ethyl-17[beta]- 
5        hydroxyestr-4-ene), 
6    (xxii) fluoxymesterone (9-fluoro-17[alpha]-methyl- 
7        1[beta],17[beta]-dihydroxyandrost-4-en-3-one), 
8    (xxiii) formebolone (2-formyl-17[alpha]-methyl-11[alpha], 
9        17[beta]-dihydroxyandrost-1,4-dien-3-one), 
10    (xxiv) furazabol (17[alpha]-methyl-17[beta]- 
11        hydroxyandrostano[2,3-c]-furazan), 
12    (xxv) 13[beta]-ethyl-17[beta]-hydroxygon-4-en-3-one) 
13    (xxvi) 4-hydroxytestosterone (4,17[beta]-dihydroxy- 
14        androst-4-en-3-one), 
15    (xxvii) 4-hydroxy-19-nortestosterone (4,17[beta]- 
16        dihydroxy-estr-4-en-3-one), 
17    (xxviii) mestanolone (17[alpha]-methyl-17[beta]- 
18        hydroxy-5-androstan-3-one), 
19    (xxix) mesterolone (1amethyl-17[beta]-hydroxy- 
20        [5a]-androstan-3-one), 
21    (xxx) methandienone (17[alpha]-methyl-17[beta]- 
22        hydroxyandrost-1,4-dien-3-one), 
23    (xxxi) methandriol (17[alpha]-methyl-3[beta],17[beta]- 
24        dihydroxyandrost-5-ene), 
25    (xxxii) methenolone (1-methyl-17[beta]-hydroxy- 
26        5[alpha]-androst-1-en-3-one), 

 

 

09700SB3329sam001- 40 -LRB097 18939 CEL 66275 a

1    (xxxiii) 17[alpha]-methyl-3[beta], 17[beta]- 
2        dihydroxy-5a-androstane), 
3    (xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy 
4        -5a-androstane), 
5    (xxxv) 17[alpha]-methyl-3[beta],17[beta]- 
6        dihydroxyandrost-4-ene), 
7    (xxxvi) 17[alpha]-methyl-4-hydroxynandrolone (17[alpha]- 
8        methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one), 
9    (xxxvii) methyldienolone (17[alpha]-methyl-17[beta]- 
10        hydroxyestra-4,9(10)-dien-3-one), 
11    (xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]- 
12        hydroxyestra-4,9-11-trien-3-one), 
13    (xxxix) methyltestosterone (17[alpha]-methyl-17[beta]- 
14        hydroxyandrost-4-en-3-one), 
15    (xl) mibolerone (7[alpha],17a-dimethyl-17[beta]- 
16        hydroxyestr-4-en-3-one), 
17    (xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone  
18        (17b[beta]-hydroxy-17[alpha]-methyl-5[alpha]- 
19        androst-1-en-3-one)(a.k.a. '17-[alpha]-methyl- 
20        1-testosterone'), 
21    (xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one), 
22    (xliii) 19-nor-4-androstenediol (3[beta], 17[beta]- 
23        dihydroxyestr-4-ene), 
24    (xliv) 19-nor-4-androstenediol (3[alpha], 17[beta]- 
25        dihydroxyestr-4-ene), 
26    (xlv) 19-nor-5-androstenediol (3[beta], 17[beta]- 

 

 

09700SB3329sam001- 41 -LRB097 18939 CEL 66275 a

1        dihydroxyestr-5-ene), 
2    (xlvi) 19-nor-5-androstenediol (3[alpha], 17[beta]- 
3        dihydroxyestr-5-ene), 
4    (xlvii) 19-nor-4,9(10)-androstadienedione  
5        (estra-4,9(10)-diene-3,17-dione), 
6    (xlviii) 19-nor-4-androstenedione (estr-4- 
7        en-3,17-dione), 
8    (xlix) 19-nor-5-androstenedione (estr-5- 
9        en-3,17-dione), 
10    (l) norbolethone (13[beta], 17a-diethyl-17[beta]- 
11        hydroxygon-4-en-3-one), 
12    (li) norclostebol (4-chloro-17[beta]- 
13        hydroxyestr-4-en-3-one), 
14    (lii) norethandrolone (17[alpha]-ethyl-17[beta]- 
15        hydroxyestr-4-en-3-one), 
16    (liii) normethandrolone (17[alpha]-methyl-17[beta]- 
17        hydroxyestr-4-en-3-one), 
18    (liv) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy- 
19        2-oxa-5[alpha]-androstan-3-one), 
20    (lv) oxymesterone (17[alpha]-methyl-4,17[beta]- 
21        dihydroxyandrost-4-en-3-one), 
22    (lvi) oxymetholone (17[alpha]-methyl-2-hydroxymethylene- 
23        17[beta]-hydroxy-(5[alpha]-androstan-3-one), 
24    (lvii) stanozolol (17[alpha]-methyl-17[beta]-hydroxy- 
25        (5[alpha]-androst-2-eno[3,2-c]-pyrazole), 
26    (lviii) stenbolone (17[beta]-hydroxy-2-methyl- 

 

 

09700SB3329sam001- 42 -LRB097 18939 CEL 66275 a

1        (5[alpha]-androst-1-en-3-one), 
2    (lix) testolactone (13-hydroxy-3-oxo-13,17- 
3        secoandrosta-1,4-dien-17-oic acid lactone), 
4    (lx) testosterone (17[beta]-hydroxyandrost- 
5        4-en-3-one), 
6    (lxi) tetrahydrogestrinone (13[beta], 17[alpha]- 
7        diethyl-17[beta]-hydroxygon- 
8        4,9,11-trien-3-one), 
9    (lxii) trenbolone (17[beta]-hydroxyestr-4,9, 
10        11-trien-3-one). 
11    Any person who is otherwise lawfully in possession of an
12anabolic steroid, or who otherwise lawfully manufactures,
13distributes, dispenses, delivers, or possesses with intent to
14deliver an anabolic steroid, which anabolic steroid is
15expressly intended for and lawfully allowed to be administered
16through implants to livestock or other nonhuman species, and
17which is approved by the Secretary of Health and Human Services
18for such administration, and which the person intends to
19administer or have administered through such implants, shall
20not be considered to be in unauthorized possession or to
21unlawfully manufacture, distribute, dispense, deliver, or
22possess with intent to deliver such anabolic steroid for
23purposes of this Act.
24    (d) "Administration" means the Drug Enforcement
25Administration, United States Department of Justice, or its
26successor agency.

 

 

09700SB3329sam001- 43 -LRB097 18939 CEL 66275 a

1    (d-5) "Clinical Director, Prescription Monitoring Program"
2means a Department of Human Services administrative employee
3licensed to either prescribe or dispense controlled substances
4who shall run the clinical aspects of the Department of Human
5Services Prescription Monitoring Program and its Prescription
6Information Library.
7    (d-10) "Compounding" means the preparation and mixing of
8components, excluding flavorings, (1) as the result of a
9prescriber's prescription drug order or initiative based on the
10prescriber-patient-pharmacist relationship in the course of
11professional practice or (2) for the purpose of, or incident
12to, research, teaching, or chemical analysis and not for sale
13or dispensing. "Compounding" includes the preparation of drugs
14or devices in anticipation of receiving prescription drug
15orders based on routine, regularly observed dispensing
16patterns. Commercially available products may be compounded
17for dispensing to individual patients only if both of the
18following conditions are met: (i) the commercial product is not
19reasonably available from normal distribution channels in a
20timely manner to meet the patient's needs and (ii) the
21prescribing practitioner has requested that the drug be
22compounded.
23    (e) "Control" means to add a drug or other substance, or
24immediate precursor, to a Schedule whether by transfer from
25another Schedule or otherwise.
26    (f) "Controlled Substance" means (i) a drug, substance, or

 

 

09700SB3329sam001- 44 -LRB097 18939 CEL 66275 a

1immediate precursor in the Schedules of Article II of this Act
2or (ii) a drug or other substance, or immediate precursor,
3designated as a controlled substance by the Department through
4administrative rule. The term does not include distilled
5spirits, wine, malt beverages, or tobacco, as those terms are
6defined or used in the Liquor Control Act and the Tobacco
7Products Tax Act.
8    (f-5) "Controlled substance analog" means a substance:
9        (1) the chemical structure of which is substantially
10    similar to the chemical structure of a controlled substance
11    in Schedule I or II;
12        (2) which has a stimulant, depressant, or
13    hallucinogenic effect on the central nervous system that is
14    substantially similar to or greater than the stimulant,
15    depressant, or hallucinogenic effect on the central
16    nervous system of a controlled substance in Schedule I or
17    II; or
18        (3) with respect to a particular person, which such
19    person represents or intends to have a stimulant,
20    depressant, or hallucinogenic effect on the central
21    nervous system that is substantially similar to or greater
22    than the stimulant, depressant, or hallucinogenic effect
23    on the central nervous system of a controlled substance in
24    Schedule I or II.
25    (g) "Counterfeit substance" means a controlled substance,
26which, or the container or labeling of which, without

 

 

09700SB3329sam001- 45 -LRB097 18939 CEL 66275 a

1authorization bears the trademark, trade name, or other
2identifying mark, imprint, number or device, or any likeness
3thereof, of a manufacturer, distributor, or dispenser other
4than the person who in fact manufactured, distributed, or
5dispensed the substance.
6    (h) "Deliver" or "delivery" means the actual, constructive
7or attempted transfer of possession of a controlled substance,
8with or without consideration, whether or not there is an
9agency relationship.
10    (i) "Department" means the Illinois Department of Human
11Services (as successor to the Department of Alcoholism and
12Substance Abuse) or its successor agency.
13    (j) (Blank).
14    (k) "Department of Corrections" means the Department of
15Corrections of the State of Illinois or its successor agency.
16    (l) "Department of Financial and Professional Regulation"
17means the Department of Financial and Professional Regulation
18of the State of Illinois or its successor agency.
19    (m) "Depressant" means any drug that (i) causes an overall
20depression of central nervous system functions, (ii) causes
21impaired consciousness and awareness, and (iii) can be
22habit-forming or lead to a substance abuse problem, including
23but not limited to alcohol, cannabis and its active principles
24and their analogs, benzodiazepines and their analogs,
25barbiturates and their analogs, opioids (natural and
26synthetic) and their analogs, and chloral hydrate and similar

 

 

09700SB3329sam001- 46 -LRB097 18939 CEL 66275 a

1sedative hypnotics.
2    (n) (Blank).
3    (o) "Director" means the Director of the Illinois State
4Police or his or her designated agents.
5    (p) "Dispense" means to deliver a controlled substance to
6an ultimate user or research subject by or pursuant to the
7lawful order of a prescriber, including the prescribing,
8administering, packaging, labeling, or compounding necessary
9to prepare the substance for that delivery.
10    (q) "Dispenser" means a practitioner who dispenses.
11    (r) "Distribute" means to deliver, other than by
12administering or dispensing, a controlled substance.
13    (s) "Distributor" means a person who distributes.
14    (t) "Drug" means (1) substances recognized as drugs in the
15official United States Pharmacopoeia, Official Homeopathic
16Pharmacopoeia of the United States, or official National
17Formulary, or any supplement to any of them; (2) substances
18intended for use in diagnosis, cure, mitigation, treatment, or
19prevention of disease in man or animals; (3) substances (other
20than food) intended to affect the structure of any function of
21the body of man or animals and (4) substances intended for use
22as a component of any article specified in clause (1), (2), or
23(3) of this subsection. It does not include devices or their
24components, parts, or accessories.
25    (t-5) "Euthanasia agency" means an entity certified by the
26Department of Financial and Professional Regulation for the

 

 

09700SB3329sam001- 47 -LRB097 18939 CEL 66275 a

1purpose of animal euthanasia that holds an animal control
2facility license or animal shelter license under the Animal
3Welfare Act. A euthanasia agency is authorized to purchase,
4store, possess, and utilize Schedule II nonnarcotic and
5Schedule III nonnarcotic drugs for the sole purpose of animal
6euthanasia.
7    (t-10) "Euthanasia drugs" means Schedule II or Schedule III
8substances (nonnarcotic controlled substances) that are used
9by a euthanasia agency for the purpose of animal euthanasia.
10    (u) "Good faith" means the prescribing or dispensing of a
11controlled substance by a practitioner in the regular course of
12professional treatment to or for any person who is under his or
13her treatment for a pathology or condition other than that
14individual's physical or psychological dependence upon or
15addiction to a controlled substance, except as provided herein:
16and application of the term to a pharmacist shall mean the
17dispensing of a controlled substance pursuant to the
18prescriber's order which in the professional judgment of the
19pharmacist is lawful. The pharmacist shall be guided by
20accepted professional standards including, but not limited to
21the following, in making the judgment:
22        (1) lack of consistency of prescriber-patient
23    relationship,
24        (2) frequency of prescriptions for same drug by one
25    prescriber for large numbers of patients,
26        (3) quantities beyond those normally prescribed,

 

 

09700SB3329sam001- 48 -LRB097 18939 CEL 66275 a

1        (4) unusual dosages (recognizing that there may be
2    clinical circumstances where more or less than the usual
3    dose may be used legitimately),
4        (5) unusual geographic distances between patient,
5    pharmacist and prescriber,
6        (6) consistent prescribing of habit-forming drugs.
7    (u-0.5) "Hallucinogen" means a drug that causes markedly
8altered sensory perception leading to hallucinations of any
9type.
10    (u-1) "Home infusion services" means services provided by a
11pharmacy in compounding solutions for direct administration to
12a patient in a private residence, long-term care facility, or
13hospice setting by means of parenteral, intravenous,
14intramuscular, subcutaneous, or intraspinal infusion.
15    (u-5) "Illinois State Police" means the State Police of the
16State of Illinois, or its successor agency.
17    (v) "Immediate precursor" means a substance:
18        (1) which the Department has found to be and by rule
19    designated as being a principal compound used, or produced
20    primarily for use, in the manufacture of a controlled
21    substance;
22        (2) which is an immediate chemical intermediary used or
23    likely to be used in the manufacture of such controlled
24    substance; and
25        (3) the control of which is necessary to prevent,
26    curtail or limit the manufacture of such controlled

 

 

09700SB3329sam001- 49 -LRB097 18939 CEL 66275 a

1    substance.
2    (w) "Instructional activities" means the acts of teaching,
3educating or instructing by practitioners using controlled
4substances within educational facilities approved by the State
5Board of Education or its successor agency.
6    (x) "Local authorities" means a duly organized State,
7County or Municipal peace unit or police force.
8    (y) "Look-alike substance" means a substance, other than a
9controlled substance which (1) by overall dosage unit
10appearance, including shape, color, size, markings or lack
11thereof, taste, consistency, or any other identifying physical
12characteristic of the substance, would lead a reasonable person
13to believe that the substance is a controlled substance, or (2)
14is expressly or impliedly represented to be a controlled
15substance or is distributed under circumstances which would
16lead a reasonable person to believe that the substance is a
17controlled substance. For the purpose of determining whether
18the representations made or the circumstances of the
19distribution would lead a reasonable person to believe the
20substance to be a controlled substance under this clause (2) of
21subsection (y), the court or other authority may consider the
22following factors in addition to any other factor that may be
23relevant:
24        (a) statements made by the owner or person in control
25    of the substance concerning its nature, use or effect;
26        (b) statements made to the buyer or recipient that the

 

 

09700SB3329sam001- 50 -LRB097 18939 CEL 66275 a

1    substance may be resold for profit;
2        (c) whether the substance is packaged in a manner
3    normally used for the illegal distribution of controlled
4    substances;
5        (d) whether the distribution or attempted distribution
6    included an exchange of or demand for money or other
7    property as consideration, and whether the amount of the
8    consideration was substantially greater than the
9    reasonable retail market value of the substance.
10    Clause (1) of this subsection (y) shall not apply to a
11noncontrolled substance in its finished dosage form that was
12initially introduced into commerce prior to the initial
13introduction into commerce of a controlled substance in its
14finished dosage form which it may substantially resemble.
15    Nothing in this subsection (y) prohibits the dispensing or
16distributing of noncontrolled substances by persons authorized
17to dispense and distribute controlled substances under this
18Act, provided that such action would be deemed to be carried
19out in good faith under subsection (u) if the substances
20involved were controlled substances.
21    Nothing in this subsection (y) or in this Act prohibits the
22manufacture, preparation, propagation, compounding,
23processing, packaging, advertising or distribution of a drug or
24drugs by any person registered pursuant to Section 510 of the
25Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
26    (y-1) "Mail-order pharmacy" means a pharmacy that is

 

 

09700SB3329sam001- 51 -LRB097 18939 CEL 66275 a

1located in a state of the United States that delivers,
2dispenses or distributes, through the United States Postal
3Service or other common carrier, to Illinois residents, any
4substance which requires a prescription.
5    (z) "Manufacture" means the production, preparation,
6propagation, compounding, conversion or processing of a
7controlled substance other than methamphetamine, either
8directly or indirectly, by extraction from substances of
9natural origin, or independently by means of chemical
10synthesis, or by a combination of extraction and chemical
11synthesis, and includes any packaging or repackaging of the
12substance or labeling of its container, except that this term
13does not include:
14        (1) by an ultimate user, the preparation or compounding
15    of a controlled substance for his or her own use; or
16        (2) by a practitioner, or his or her authorized agent
17    under his or her supervision, the preparation,
18    compounding, packaging, or labeling of a controlled
19    substance:
20            (a) as an incident to his or her administering or
21        dispensing of a controlled substance in the course of
22        his or her professional practice; or
23            (b) as an incident to lawful research, teaching or
24        chemical analysis and not for sale.
25    (z-1) (Blank).
26    (z-5) "Medication shopping" means the conduct prohibited

 

 

09700SB3329sam001- 52 -LRB097 18939 CEL 66275 a

1under subsection (a) of Section 314.5 of this Act.
2    (z-10) "Mid-level practitioner" means (i) a physician
3assistant who has been delegated authority to prescribe through
4a written delegation of authority by a physician licensed to
5practice medicine in all of its branches, in accordance with
6Section 7.5 of the Physician Assistant Practice Act of 1987,
7(ii) an advanced practice nurse who has been delegated
8authority to prescribe through a written delegation of
9authority by a physician licensed to practice medicine in all
10of its branches or by a podiatrist, in accordance with Section
1165-40 of the Nurse Practice Act, or (iii) an animal euthanasia
12agency.
13    (aa) "Narcotic drug" means any of the following, whether
14produced directly or indirectly by extraction from substances
15of vegetable origin, or independently by means of chemical
16synthesis, or by a combination of extraction and chemical
17synthesis:
18        (1) opium, opiates, derivatives of opium and opiates,
19    including their isomers, esters, ethers, salts, and salts
20    of isomers, esters, and ethers, whenever the existence of
21    such isomers, esters, ethers, and salts is possible within
22    the specific chemical designation; however the term
23    "narcotic drug" does not include the isoquinoline
24    alkaloids of opium;
25        (2) (blank);
26        (3) opium poppy and poppy straw;

 

 

09700SB3329sam001- 53 -LRB097 18939 CEL 66275 a

1        (4) coca leaves, except coca leaves and extracts of
2    coca leaves from which substantially all of the cocaine and
3    ecgonine, and their isomers, derivatives and salts, have
4    been removed;
5        (5) cocaine, its salts, optical and geometric isomers,
6    and salts of isomers;
7        (6) ecgonine, its derivatives, their salts, isomers,
8    and salts of isomers;
9        (7) any compound, mixture, or preparation which
10    contains any quantity of any of the substances referred to
11    in subparagraphs (1) through (6).
12    (bb) "Nurse" means a registered nurse licensed under the
13Nurse Practice Act.
14    (cc) (Blank).
15    (dd) "Opiate" means any substance having an addiction
16forming or addiction sustaining liability similar to morphine
17or being capable of conversion into a drug having addiction
18forming or addiction sustaining liability.
19    (ee) "Opium poppy" means the plant of the species Papaver
20somniferum L., except its seeds.
21    (ee-5) "Oral dosage" means a tablet, capsule, elixir, or
22solution or other liquid form of medication intended for
23administration by mouth, but the term does not include a form
24of medication intended for buccal, sublingual, or transmucosal
25administration.
26    (ff) "Parole and Pardon Board" means the Parole and Pardon

 

 

09700SB3329sam001- 54 -LRB097 18939 CEL 66275 a

1Board of the State of Illinois or its successor agency.
2    (gg) "Person" means any individual, corporation,
3mail-order pharmacy, government or governmental subdivision or
4agency, business trust, estate, trust, partnership or
5association, or any other entity.
6    (hh) "Pharmacist" means any person who holds a license or
7certificate of registration as a registered pharmacist, a local
8registered pharmacist or a registered assistant pharmacist
9under the Pharmacy Practice Act.
10    (ii) "Pharmacy" means any store, ship or other place in
11which pharmacy is authorized to be practiced under the Pharmacy
12Practice Act.
13    (ii-5) "Pharmacy shopping" means the conduct prohibited
14under subsection (b) of Section 314.5 of this Act.
15    (ii-10) "Physician" (except when the context otherwise
16requires) means a person licensed to practice medicine in all
17of its branches.
18    (jj) "Poppy straw" means all parts, except the seeds, of
19the opium poppy, after mowing.
20    (kk) "Practitioner" means a physician licensed to practice
21medicine in all its branches, dentist, optometrist,
22podiatrist, veterinarian, prescribing psychologist, scientific
23investigator, pharmacist, physician assistant, advanced
24practice nurse, licensed practical nurse, registered nurse,
25hospital, laboratory, or pharmacy, or other person licensed,
26registered, or otherwise lawfully permitted by the United

 

 

09700SB3329sam001- 55 -LRB097 18939 CEL 66275 a

1States or this State to distribute, dispense, conduct research
2with respect to, administer or use in teaching or chemical
3analysis, a controlled substance in the course of professional
4practice or research.
5    (ll) "Pre-printed prescription" means a written
6prescription upon which the designated drug has been indicated
7prior to the time of issuance; the term does not mean a written
8prescription that is individually generated by machine or
9computer in the prescriber's office.
10    (mm) "Prescriber" means a physician licensed to practice
11medicine in all its branches, dentist, optometrist,
12podiatrist, prescribing psychologist, or veterinarian who
13issues a prescription, a physician assistant who issues a
14prescription for a controlled substance in accordance with
15Section 303.05, a written delegation, and a written supervision
16agreement required under Section 7.5 of the Physician Assistant
17Practice Act of 1987, or an advanced practice nurse with
18prescriptive authority delegated under Section 65-40 of the
19Nurse Practice Act and in accordance with Section 303.05, a
20written delegation, and a written collaborative agreement
21under Section 65-35 of the Nurse Practice Act.
22    (nn) "Prescription" means a written, facsimile, or oral
23order, or an electronic order that complies with applicable
24federal requirements, of a physician licensed to practice
25medicine in all its branches, dentist, podiatrist, prescribing
26psychologist, or veterinarian for any controlled substance, of

 

 

09700SB3329sam001- 56 -LRB097 18939 CEL 66275 a

1an optometrist for a Schedule III, IV, or V controlled
2substance in accordance with Section 15.1 of the Illinois
3Optometric Practice Act of 1987, of a physician assistant for a
4controlled substance in accordance with Section 303.05, a
5written delegation, and a written supervision agreement
6required under Section 7.5 of the Physician Assistant Practice
7Act of 1987, or of an advanced practice nurse with prescriptive
8authority delegated under Section 65-40 of the Nurse Practice
9Act who issues a prescription for a controlled substance in
10accordance with Section 303.05, a written delegation, and a
11written collaborative agreement under Section 65-35 of the
12Nurse Practice Act when required by law.
13    (nn-5) "Prescription Information Library" (PIL) means an
14electronic library that contains reported controlled substance
15data.
16    (nn-10) "Prescription Monitoring Program" (PMP) means the
17entity that collects, tracks, and stores reported data on
18controlled substances and select drugs pursuant to Section 316.
19    (oo) "Production" or "produce" means manufacture,
20planting, cultivating, growing, or harvesting of a controlled
21substance other than methamphetamine.
22    (pp) "Registrant" means every person who is required to
23register under Section 302 of this Act.
24    (qq) "Registry number" means the number assigned to each
25person authorized to handle controlled substances under the
26laws of the United States and of this State.

 

 

09700SB3329sam001- 57 -LRB097 18939 CEL 66275 a

1    (qq-5) "Secretary" means, as the context requires, either
2the Secretary of the Department or the Secretary of the
3Department of Financial and Professional Regulation, and the
4Secretary's designated agents.
5    (rr) "State" includes the State of Illinois and any state,
6district, commonwealth, territory, insular possession thereof,
7and any area subject to the legal authority of the United
8States of America.
9    (rr-5) "Stimulant" means any drug that (i) causes an
10overall excitation of central nervous system functions, (ii)
11causes impaired consciousness and awareness, and (iii) can be
12habit-forming or lead to a substance abuse problem, including
13but not limited to amphetamines and their analogs,
14methylphenidate and its analogs, cocaine, and phencyclidine
15and its analogs.
16    (ss) "Ultimate user" means a person who lawfully possesses
17a controlled substance for his or her own use or for the use of
18a member of his or her household or for administering to an
19animal owned by him or her or by a member of his or her
20household.
21(Source: P.A. 96-189, eff. 8-10-09; 96-268, eff. 8-11-09;
2297-334, eff. 1-1-12.)
 
23    Section 99. Effective date. This Act takes effect upon
24becoming law.".